Associate Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Hematology
Dr. Udit N. Verma, MD
|
|
Give Review
Udit N. Verma is an expert in the field of Hematology. He went to medical school at University of Texas Southwestern Medical School. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Udit N. Verma is a published doctor as well. He has 25 publications published. The latest was: Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells. Udit N. Verma is registered with Medicare.
Publications
- Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension.
- Cells lacking IKK? show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKK? as a tumor suppressor.
- Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
- Phase I dose escalation study With irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients With solid malignancies.
- IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation.
- Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
- Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression.
- Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon Cancer cells.
- Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung Cancer cell lines by inhibition of nuclear factor-kappaB.
- Interleukin-12 (IL-12) alone or in synergistic combination With IL-2 for in vitro activation of human bone marrow: differential effects at different time points.
- Interleukin-2 activation of chemotherapy and growth factor-mobilized peripheral blood stem cells for generation of cytotoxic effectors.
- Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a...
- Interleukin-2-activated hematopoietic stem cell transplantation for breast Cancer: investigation of dose level with clinical correlates.
- Paclitaxel vs cyclophosphamide in peripheral blood stem cell mobilization: comparative studies in a murine model.
- An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients With solid tumors.
- A pilot trial of GM-CSF and MDX-H210 in patients With erbB-2-positive advanced malignancies.
- Towards endothelial-cell-directed Cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
- Regulation of beta-catenin function by the IkappaB kinases.
- IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex.
- Protein phosphatase 2Cbeta association With the IkappaB kinase complex is involved in regulating NF-kappaB activity.
- IKKalpha regulates mitogenic signaling through transcriptional inDuction of cyclin D1 via Tcf.
- Identification and validation of genes involved in the pathogenesis of colorectal Cancer using cDNA microarrays and RNA interference.
- Efficacy of sequential treatment of HCT116 colon Cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil.
- Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
Schools
Memorial Medical College Lucknow University
King Georges Medical College
Zale Lipshy University Hospital
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Texas Southwestern Medical School -
Charleston Area Medical Center - WVSOM
Hospital
-
University of Texas Southwestern Medical Center
Drug Facts
| NPI NUMBER | 1033178165 | |
| NPPES Provider LastName | VERMA | |
| NPPES Provider FirstName | UDIT | |
| NPPES Provider ZIPCode | 753908852 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 967.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 125.0 | |
| Percent Opioid Claims | 12.93 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033178165 |
| Last Name Of The Provider | VERMA |
| First Name Of The Provider | UDIT |
| View All |
Similar Doctors
|
|
Dr. Prapti A. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry C. Mirtsching, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaya V. Juturi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabeel Sarhill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall S. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Nijhawan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nghia Andy D. Nguyen, MD |
|
|
Dr. Adam J. Hoffhines, MD |
|
|
Dr. Grace L. Lee, MD |
|
|
Dr. Mary H. Rivero-Homer, MD |
|
|
Dr. Ameen A. Salahudeen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ashwani K. Agarwal, MB
This Doctor is OpenDoctor Recommended.
|